Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection
about
Multipurpose prevention technologies: the future of HIV and STI protectionEngineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancyA review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzeeHistorical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.An intravaginal ring for the sustained delivery of antibodies.Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection.Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures.Effect of tenofovir on nucleotidases and cytokines in HIV-1 target cells.Adolescents' and young women's use of a microbicide surrogate product when receiving oral sex.Chronic HIV Infection Is Associated with Upregulation of Proinflammatory Cytokine and Chemokine and Alpha Defensin Gene Expression in Colorectal MucosaBiophysical characterization of small molecule antiviral-loaded nanolipogels for HIV-1 chemoprophylaxis and topical mucosal application.The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in femalesAn intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate.Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial.A perspective on progress and gaps in HIV prevention scienceImpact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir GelPartial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220.Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaquesA phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral releaseLearning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse ModelMicrobicides: still a long road to successIntravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary propertiesGriffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.Vaginally delivered tenofovir disoproxil fumarate provides greater protection than tenofovir against genital herpes in a murine model of efficacy and safety.Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.Current progress in development of hepatitis C virus vaccines.An overview of antiretroviral pre-exposure prophylaxis of HIV infection.Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease.Beyond HIV microbicides: multipurpose prevention technology products.Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice.Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections in vitro.
P2860
Q26827796-35E07621-9AE8-4F84-B6BE-C5445516C905Q28540419-CF26276E-5C1A-4A58-AB6D-981203910592Q30431343-D28A643F-804D-458B-8A0B-E5B5D120F7C0Q33442370-0C47CF50-C74A-42C4-8FE0-7DFDC96E9844Q33821090-E7F31774-9411-4387-A939-CEBD00D6E271Q34353780-3D5B1B5A-4B92-4A6F-9046-07287FBF5E68Q34389166-2C3489B3-2435-4D81-AFCE-04A1C6D21C16Q34495644-39A7D189-A3CA-4D1E-B2E5-4F431029AE34Q34673931-AE49212D-1EB7-4A3B-8DF8-DF312B38D740Q35036745-FC24DDE9-CA75-4128-88B0-1C14CF9C2246Q35193937-1A6C85B6-2F5C-4E49-A1B6-9BABE1AAAD2BQ35692231-CC6DEC25-BB68-4129-B8D4-20E88B714C60Q35947035-08433BB5-975A-4DDA-9D9D-9B382EC9C846Q35973578-8FADB2BB-17AA-44C1-9C96-0C5C11D6D1CCQ36173112-12557B08-76DB-404E-B1EC-3FA7BA6F315DQ36173759-0790DEA6-489C-4877-AA3A-E45C6DE77AA9Q36306926-EA820EDD-5773-4FB3-8363-9440FF3F8290Q36358897-E00C202E-C5A9-4E20-A06B-3D9EA4F1C31CQ36446138-F513C23A-AE9F-4FB2-91CB-50D73463E838Q36526657-DBE56810-4167-4C2A-A43A-6899B0354BB3Q36593663-CC331E39-1FF0-4B71-890B-AF1604C342E7Q36619482-9F3E8DAC-BCC7-44C6-A71F-9CD1A8D82C90Q36644606-C62200A1-5D45-4C43-96EE-2429BC0BCD8FQ36666807-EBAAC4EC-10A9-4152-9ECE-0CFCE6AECDF8Q36807121-270D9773-F79D-46C4-AC41-401FA9F37EC2Q36933427-555BDDBF-C7DF-4103-B288-6331E832959DQ37130757-460E34B1-D9B5-4082-B03D-C78A66EEEA8EQ37218578-FFCD304F-3BEC-4328-AFFC-E1B039F24927Q37255082-F0AF774F-7EC4-42C0-A92D-96BE491F8762Q37308347-D5918C38-3EB3-4C9C-A333-B907CF518AA1Q37358616-9522AC46-F341-4254-83FC-D53969330380Q37544735-0FFFB95D-51E7-4356-A98C-5EAC7A2E0C63Q37694939-57C5C9E1-C428-4CE0-A393-B4125531C212Q38120201-44055A0A-D01A-4204-8F97-3EA0D3AABF10Q38196410-788CA9CF-D769-4B01-A09E-C2500DA2649EQ38248209-020FAB1A-2FEC-4696-9521-C35876A47239Q38261814-84C160FB-2D66-4190-92D6-77192531EA6CQ39063908-019322CC-1833-4197-843F-9B6FE832CB6CQ40062702-693E0AE8-1033-4ADC-AD37-8657B9DF2F06Q40086722-CAB5BE6E-7734-4791-BA40-E9821CB38CAF
P2860
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intravaginal ring delivery of ...... herpes simplex virus infection
@ast
Intravaginal ring delivery of ...... herpes simplex virus infection
@en
type
label
Intravaginal ring delivery of ...... herpes simplex virus infection
@ast
Intravaginal ring delivery of ...... herpes simplex virus infection
@en
prefLabel
Intravaginal ring delivery of ...... herpes simplex virus infection
@ast
Intravaginal ring delivery of ...... herpes simplex virus infection
@en
P2093
P2860
P356
P1476
Intravaginal ring delivery of ...... herpes simplex virus infection
@en
P2093
Ashley M Huber
Betsy C Herold
N Merna Torres
Patrick F Kiser
Pedro M M Mesquita
Rachna Rastogi
Ryan S Teller
Theodore J Segarra
P2860
P304
P356
10.1093/JAC/DKS097
P407
P577
2012-03-30T00:00:00Z